Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia

NCT04469114 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

289

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Tofacitinib 10 mg
DRUG: Placebo

Sponsor

Hospital Israelita Albert Einstein

Collaborators

[object Object]